Voloridge Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-29,093
| Closed | -$174K | – | 1151 |
|
|
2024
Q4 | $174K | Buy |
+29,093
| New | +$174K | ﹤0.01% | 1144 |
|
|
2024
Q1 | – | Sell |
-51,375
| Closed | -$252K | – | 1121 |
|
|
2023
Q4 | $252K | Sell |
51,375
-193,820
| -79% | -$950K | ﹤0.01% | 1095 |
|
|
2023
Q3 | $1.34M | Buy |
245,195
+51,462
| +27% | +$280K | 0.01% | 1035 |
|
|
2023
Q2 | $1.3M | Sell |
193,733
-142,834
| -42% | -$958K | 0.01% | 1069 |
|
|
2023
Q1 | $2.97M | Sell |
336,567
-71,067
| -17% | -$628K | 0.01% | 848 |
|
|
2022
Q4 | $3.11M | Buy |
407,634
+105,880
| +35% | +$809K | 0.02% | 838 |
|
|
2022
Q3 | $2.15M | Buy |
301,754
+86,496
| +40% | +$616K | 0.01% | 968 |
|
|
2022
Q2 | $1.74M | Buy |
215,258
+130,802
| +155% | +$1.06M | 0.01% | 1055 |
|
|
2022
Q1 | $1.17M | Buy |
84,456
+52,863
| +167% | +$734K | 0.01% | 1093 |
|
|
2021
Q4 | $886K | Buy |
31,593
+24,475
| +344% | +$686K | ﹤0.01% | 1295 |
|
|
2021
Q3 | $242K | Sell |
7,118
-100,859
| -93% | -$3.43M | ﹤0.01% | 1562 |
|
|
2021
Q2 | $4.41M | Sell |
107,977
-25,817
| -19% | -$1.05M | 0.03% | 689 |
|
|
2021
Q1 | $5.39M | Sell |
133,794
-89,545
| -40% | -$3.61M | 0.04% | 507 |
|
|
2020
Q4 | $13.2M | Buy |
223,339
+123,836
| +124% | +$7.32M | 0.11% | 219 |
|
|
2020
Q3 | $4.84M | Buy |
99,503
+77,603
| +354% | +$3.77M | 0.04% | 455 |
|
|
2020
Q2 | $1.06M | Buy |
+21,900
| New | +$1.06M | 0.01% | 835 |
|